Autolus Therapeutics Announces Publication in Molecular Therapy

April 4, 2023

https://www.globenewswire.com/news-release/2023/04/04/2640461/0/en/Autolus-Therapeutics-Announces-Publication-in-Molecular-Therapy.html

– Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR

– AUTO1/22 may reduce CD19 negative escape in children with B-ALL, and may have broader applications in improving outcomes in other B-cell malignancies

Read more at globenewswire.com

Related news for (AUTL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.